You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Quizartinib added to SOC

Showing 1 - 25 of 4,789
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
May 18, 2022

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma Trial (DCVAC/OvCa, DCVAC/OvCa )

Withdrawn
  • Ovarian Cancer
  • +2 more
  • DCVAC/OvCa
  • DCVAC/OvCa placebo
  • (no location specified)
Dec 6, 2021

Stage IV NSCLC Trial in Czechia, Slovakia (DCVAC add on to SOC, DCVAC and immune enhancers add on to SOC, Standard of Care

Completed
  • Stage IV Non-small Cell Lung Cancer
  • DCVAC add on to SOC
  • +2 more
  • Brno, Czechia
  • +17 more
May 3, 2022

Tuberculosis, Pulmonary, Tuberculosis, MDR, Tuberculosis Infection Trial in Tbilisi, Soweto, Klerksdorp (Control group, ASA

Recruiting
  • Tuberculosis, Pulmonary
  • +2 more
  • Control group
  • +3 more
  • Tbilisi, Georgia
  • +2 more
Apr 6, 2021

Healthy Subjects Trial in Nottingham (Quizartinib diHCl, 14C-Quizartinib solution for infusion)

Completed
Has Results
  • Healthy Subjects
  • Quizartinib dihydrochloride
  • 14C-Quizartinib solution for infusion
  • Nottingham, United Kingdom
    Quotient Sciences
Apr 15, 2022

Refractory Status Epilepticus Trial in Worldwide (Ganaxolone, Placebo, Standard of care)

Not yet recruiting
  • Refractory Status Epilepticus
  • Bruxelles, Belgium
  • +11 more
Apr 3, 2023

Advanced or Metastatic Colorectal Cancer Trial in Worldwide (Amivantamab, Fluorouracil, Leucovorin)

Recruiting
  • Advanced or Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +85 more
Jan 27, 2023

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (SAR445088 (IV), SAR445088 (SC))

Recruiting
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
  • SAR445088 (IV)
  • SAR445088 (SC)
  • Los Angeles, California
  • +28 more
Aug 24, 2022

COVID-19 Trial in Jakarta, Bandung (Standard of Care + Quinine Sulfate, Standard of Care)

Recruiting
  • COVID-19
  • Standard of Care + Quinine Sulfate
  • Standard of Care
  • Jakarta, DKI Jakarta, Indonesia
  • +1 more
Apr 10, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Hip Injuries Trial in Englewood (BFR)

Recruiting
  • Hip Injuries
  • BFR
  • Englewood, Colorado
    UCHealth Steadman Hawkins Clinic Denver
May 3, 2022

Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)

Completed
  • Covid19
  • Remdesivir
  • +4 more
  • Tucson, Arizona
  • +39 more
Dec 16, 2022

Substance Use Disorders, HIV Trial in Los Angeles (PrEP navigation + text messaging, Standard of Care, Contingency Management)

Recruiting
  • Substance Use Disorders
  • HIV
  • PrEP navigation + text messaging
  • +2 more
  • Los Angeles, California
    Friends Community Center
Jun 28, 2023

Cutaneous Malignant Melanoma Trial in Cleveland (Low Dose Rate Brachytherapy (LDR), Standard-of-Care Immunotherapy)

Recruiting
  • Cutaneous Malignant Melanoma
  • Low Dose Rate Brachytherapy (LDR)
  • Standard-of-Care Immunotherapy
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Aug 10, 2022

SARS-CoV-2 Trial in United States (Standard of Care (SOC) and Colchicine+Rosuvastatin)

Completed
  • SARS-CoV-2
  • Standard of Care (SOC) and Colchicine+Rosuvastatin
  • Bridgeport, Connecticut
  • +3 more
May 12, 2022

Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • FLT3 Gene Mutation Negative
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

NSCLC, Non-Small-Cell Lung Carcinoma, Circulating Tumor DNA Trial (biological, drug, other)

Withdrawn
  • Non-Small Cell Lung Cancer
  • +2 more
  • Nivolumab
  • +8 more
  • (no location specified)
Mar 9, 2022

pH, Microbiome, Dental Plaque Trial (Stevioside)

Not yet recruiting
  • pH
  • +2 more
  • (no location specified)
May 5, 2023

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
May 23, 2022

Diabetic Nephropathy Trial in Worldwide (Nidufexor, Placebo, Standard of Care (SoC))

Completed
Has Results
  • Diabetic Nephropathy
  • Miami Lakes, Florida
  • +17 more
Aug 8, 2022

TRAQinform Assessment of Immunotherapy Response

Not yet recruiting
  • Melanoma
  • Non-Interventional
  • (no location specified)
Apr 6, 2023

Diabetic Foot Ulcer Trial in Mobile, Saint George (Tenex TXB MicroTip Ultrasound system plus SOC, Standard of Care for diabetic

Not yet recruiting
  • Diabetic Foot Ulcer
  • Tenex TXB MicroTip Ultrasound system plus SOC
  • Standard of Care for diabetic foot ulcer
  • Mobile, Alabama
  • +1 more
Nov 16, 2023

Acute Myeloid Leukemia Trial in Worldwide (Quizartinib, Intrathecal (IT) triple chemo prophylaxis, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Loma Linda, California
  • +36 more
Feb 1, 2023